Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Muscle Nerve. 2022 Jan 22;65(5):593–598. doi: 10.1002/mus.27484

Table 1-.

Comparison of comorbidities and anthropomorphic variables between patients with LRPN and controls

Variables LRPN
n=59
Controls
n=177
p
Yes, N % Yes, N %
Hypertension 38 64 79 45 0.009
Diabetes Mellitus 39 66 35 20 <0.001
Obesity 30 51 59 33 0.021
Dyslipidemia 39 66 72 41 <0.001
CKD 9 15 18 11 0.288
Stroke 8 14 7 4 0.009
Heart failure 5 8 14 8 0.890
CAD 18 31 34 19 0.07
PAD 1 2 6 3 0.506
Dementia 4 7 2 1 0.017
Comorbid autoimmune disorder 9 15 11 6 0.031
Cancer 15 25 35 20 0.356
Median range Median range
BMI, kg/m2 31.4 18.4-57.5 28 16.1-47.7 <0.001
Weight, kgs 90.3 53-172 79.6 37.8-181 <0.001
Height, cms 171 135-188 168 98.9-196 0.36

LRPN- lumbosacral radiculoplexus neuropathy; CKD- chronic kidney disease; CAD- coronary artery disease; PAD- peripheral artery disease; BMI- body mass index; kgs- kilograms; cms- centimeters